SCHEMBL7602597

SCHEMBL7602597

NS(=O)(=O)Nc1ccc2nc(N[C@@H]3CCc4ccccc43)ccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
FADS1 O60427 1/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
NAE1 Q13564 3/20 0.40
UBA3 Q8TBC4 3/20 0.40
CDK1 P06493 1/20 0.38
PFKFB3 Q16875 3/20 0.38
GLP1R P43220 1/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SCN1A P35498 2/20 0.37
SCN5A Q14524 2/20 0.37
SCN8A Q9UQD0 2/20 0.37
CHEK2 O96017 1/20 0.37
HPGDS O60760 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4097363 0.99 CA1 (0.48) CA1CA2FADS1DDB1CRBN
SCHEMBL3412817 0.87 SMN1; SMN2 (0.42) CA1CA2FADS1DDB1CRBN
SCHEMBL4116784 0.87 CA1 (0.41) CA1CA2FADS1DDB1CRBN
SCHEMBL4098123 0.85 DDB1 (0.39) CA1CA2FADS1DDB1CRBN
SCHEMBL4100050 0.84 MAPT (0.43) PFKFB3KDM4ELMNATSHRSMN1; SMN2
SCHEMBL4097398 0.84 KDM4E (0.38) CA1CA2FADS1DDB1CRBN
SCHEMBL3414984 0.83 AURKA (0.41) CA1CA2FADS1DDB1CRBN
SCHEMBL7602604 0.83 LMNA (0.50) FADS1GLP1RKDM4ELMNATSHR
SCHEMBL4108477 0.83 KDM4E (0.40) CA1CA2FADS1DDB1CRBN
SCHEMBL4104986 0.82 LMNA (0.39) CA1CA2FADS1DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183380-B2 2-aminoquinolines HOFFMANN-LA ROCHE INC. (US) 2012-05-22 US disclosed
US-8183380-B2 2-aminoquinolines HOFFMANN-LA ROCHE INC. (US) 2012-05-22 US disclosed
WO-2009109477-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 2009-09-11 WO disclosed
US-20090227570-A1 2-AMINOQUINOLINES HOFFMANN-LA ROCHE, INC. 2009-09-10 US disclosed
US-20090227570-A1 2-AMINOQUINOLINES HOFFMANN-LA ROCHE, INC. 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227570-A1 2-AMINOQUINOLINES HTR5A, HTR2C, HTR2A CA1 4593/4885CA2 3165/4885FADS1 2068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.